Immunome, Inc.IMNMNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 100% recommend buying.
Consensus Rating
Buy
9 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
9100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 32% higher.
Bear Case
$26.00
-1%
Consensus
$34.50
+32%
Bull Case
$40.00
+53%
Price Range9 analysts
Low
Consensus
High
$26.00
$40.00
Current Target
Current Price
$26.14
Upside to Target
$8.36
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.